Artivion | CRY - Выручка от реализации





Продажи Изменить Дата
Abbott USD 12.59B 1.43B 2026-06
Accuray USD 116.17M 14.63M 2024-12
AngioDynamics USD 79.43M 3.72M 2025-09
Artivion USD 115.99M 2.6M 2025-12
AtriCure USD 153.6M 12.4M 2026-06
Baxter International USD 2.96B 260M 2026-06
Becton, Dickinson and Co. USD 5B 300M 2026-06
Boston Scientific USD 5.44B 240M 2026-06
Edwards Lifesciences USD 1.74B 90M 2026-06
Inogen USD 74.93M 504K 2024-09
Integra LifeSciences USD 418.8M 26.9M 2026-06
J&J USD 25.31B 1.21B 2026-06
Mesa Laboratories USD 62.84M 5.01M 2024-12
Orthofix International USD 219.91M 14.28M 2025-12
Pfizer USD 15.03B 530M 2026-06
ResMed USD 1.46B 60M 2026-06
Stryker USD 6.6B 600M 2026-06
Tandem Diabetes Care USD 254.6M 7.38M 2026-06
Teleflex USD 570.3M 22M 2026-06
Terumo JPY 311.81B 11.49B 2026-06
Trinity Biotech USD 11.07M 3.24M 2025-12